• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中数据驱动的因果模型发现与个性化预测

Data-driven causal model discovery and personalized prediction in Alzheimer's disease.

作者信息

Zheng Haoyang, Petrella Jeffrey R, Doraiswamy P Murali, Lin Guang, Hao Wenrui

机构信息

School of Mechanical Engineering, Purdue University, West Lafayette, 47907, IN, USA.

Department of Radiology, Duke University Health System, Durham, 27710, NC, USA.

出版信息

NPJ Digit Med. 2022 Sep 8;5(1):137. doi: 10.1038/s41746-022-00632-7.

DOI:10.1038/s41746-022-00632-7
PMID:36076010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9458727/
Abstract

With the explosive growth of biomarker data in Alzheimer's disease (AD) clinical trials, numerous mathematical models have been developed to characterize disease-relevant biomarker trajectories over time. While some of these models are purely empiric, others are causal, built upon various hypotheses of AD pathophysiology, a complex and incompletely understood area of research. One of the most challenging problems in computational causal modeling is using a purely data-driven approach to derive the model's parameters and the mathematical model itself, without any prior hypothesis bias. In this paper, we develop an innovative data-driven modeling approach to build and parameterize a causal model to characterize the trajectories of AD biomarkers. This approach integrates causal model learning, population parameterization, parameter sensitivity analysis, and personalized prediction. By applying this integrated approach to a large multicenter database of AD biomarkers, the Alzheimer's Disease Neuroimaging Initiative, several causal models for different AD stages are revealed. In addition, personalized models for each subject are calibrated and provide accurate predictions of future cognitive status.

摘要

随着阿尔茨海默病(AD)临床试验中生物标志物数据的爆炸式增长,人们开发了许多数学模型来描述与疾病相关的生物标志物随时间的变化轨迹。虽然其中一些模型纯粹是经验性的,但其他模型是因果性的,基于AD病理生理学的各种假设构建,而这是一个复杂且尚未完全理解的研究领域。计算因果模型中最具挑战性的问题之一是使用纯粹的数据驱动方法来推导模型参数和数学模型本身,而不存在任何先验假设偏差。在本文中,我们开发了一种创新的数据驱动建模方法,以构建和参数化一个因果模型来描述AD生物标志物的变化轨迹。这种方法整合了因果模型学习、总体参数化、参数敏感性分析和个性化预测。通过将这种综合方法应用于一个大型多中心AD生物标志物数据库——阿尔茨海默病神经影像学计划,揭示了针对不同AD阶段的几种因果模型。此外,还为每个受试者校准了个性化模型,并对未来认知状态提供了准确预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/de3c5a43c985/41746_2022_632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/5ae9001d8dba/41746_2022_632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/7b677798b088/41746_2022_632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/de3c5a43c985/41746_2022_632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/5ae9001d8dba/41746_2022_632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/7b677798b088/41746_2022_632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9458727/de3c5a43c985/41746_2022_632_Fig5_HTML.jpg

相似文献

1
Data-driven causal model discovery and personalized prediction in Alzheimer's disease.阿尔茨海默病中数据驱动的因果模型发现与个性化预测
NPJ Digit Med. 2022 Sep 8;5(1):137. doi: 10.1038/s41746-022-00632-7.
2
Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade.阿尔茨海默病生物标志物级联的个性化计算因果建模
J Prev Alzheimers Dis. 2024;11(2):435-444. doi: 10.14283/jpad.2023.134.
3
Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.阿尔茨海默病中动态生物标志物级联的计算因果建模。
Comput Math Methods Med. 2019 Feb 3;2019:6216530. doi: 10.1155/2019/6216530. eCollection 2019.
4
Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model.通过个性化数学模型优化阿尔茨海默病的抗β淀粉样蛋白治疗。
PLoS Comput Biol. 2022 Sep 2;18(9):e1010481. doi: 10.1371/journal.pcbi.1010481. eCollection 2022 Sep.
5
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.了解疾病进展和改善阿尔茨海默病临床试验:阿尔茨海默病神经影像学倡议的最新重点。
Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13.
6
Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.阿尔茨海默病进展多项指标的纵向暴露-反应建模。
J Prev Alzheimers Dis. 2023;10(2):212-222. doi: 10.14283/jpad.2023.13.
7
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.阿尔茨海默病神经影像学计划2014年更新:自启动以来发表论文综述
Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001.
8
c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.c-Diadem:一种受限双输入深度学习模型,用于识别阿尔茨海默病中的新型生物标志物。
BMC Med Genomics. 2023 Oct 13;16(Suppl 2):244. doi: 10.1186/s12920-023-01675-9.
9
A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.一种参数高效的深度学习方法,用于预测轻度认知障碍向阿尔茨海默病的转化。
Neuroimage. 2019 Apr 1;189:276-287. doi: 10.1016/j.neuroimage.2019.01.031. Epub 2019 Jan 14.
10
Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain β-amyloid pathology.结合血浆生物标志物和认知评估的综合算法能准确预测脑β-淀粉样蛋白病变。
Commun Med (Lond). 2023 May 10;3(1):65. doi: 10.1038/s43856-023-00295-9.

引用本文的文献

1
Applications and challenges of biomarker-based predictive models in proactive health management.基于生物标志物的预测模型在主动健康管理中的应用与挑战
Front Public Health. 2025 Aug 18;13:1633487. doi: 10.3389/fpubh.2025.1633487. eCollection 2025.
2
Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression.通过算子学习了解阿尔茨海默病进展中患者特异性空间生物标志物动态变化。
ArXiv. 2025 Jul 22:arXiv:2507.16148v1.
3
DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer's disease.

本文引用的文献

1
An integrated framework for building trustworthy data-driven epidemiological models: Application to the COVID-19 outbreak in New York City.建立可信数据驱动的流行病学模型的综合框架:在纽约市 COVID-19 爆发中的应用。
PLoS Comput Biol. 2021 Sep 8;17(9):e1009334. doi: 10.1371/journal.pcbi.1009334. eCollection 2021 Sep.
2
Bayesian Physics-Based Modeling of Tau Propagation in Alzheimer's Disease.基于贝叶斯物理模型的阿尔茨海默病中tau蛋白传播研究
Front Physiol. 2021 Jul 16;12:702975. doi: 10.3389/fphys.2021.702975. eCollection 2021.
3
Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer.
DeepDrug是一种由专家指导和人工智能驱动的药物重新利用方法,用于选择治疗阿尔茨海默病的先导药物组合。
Sci Rep. 2025 Jan 15;15(1):2093. doi: 10.1038/s41598-025-85947-7.
4
Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms.超越常见的嫌疑对象:寻找神经退行性疾病机制的多因素计算模型。
Transl Psychiatry. 2024 Sep 23;14(1):386. doi: 10.1038/s41398-024-03073-w.
5
Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.阿尔茨海默病全基因组关联研究的知识领域和新兴趋势:2002 年至 2022 年的文献计量分析和可视化研究。
PLoS One. 2024 Jan 19;19(1):e0295008. doi: 10.1371/journal.pone.0295008. eCollection 2024.
6
Data-driven care for patients with neurodegenerative disorders.针对神经退行性疾病患者的数据驱动型护理。
Nat Rev Neurol. 2023 Aug;19(8):447-448. doi: 10.1038/s41582-023-00828-9.
基于数据驱动的结肠癌FOLFIRI治疗数学模型
Cancers (Basel). 2021 May 27;13(11):2632. doi: 10.3390/cancers13112632.
4
Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology.纵向认知和生物标志物测量支持阿尔茨海默病病理生理学中的单向途径。
Biol Psychiatry. 2021 Apr 15;89(8):786-794. doi: 10.1016/j.biopsych.2020.06.029. Epub 2020 Jul 12.
5
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases.机器学习在神经退行性疾病诊断和治疗中的应用。
Nat Rev Neurol. 2020 Aug;16(8):440-456. doi: 10.1038/s41582-020-0377-8. Epub 2020 Jul 15.
6
Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions.阿尔茨海默病;病理生理基础和治疗干预的综述。
Life Sci. 2020 Sep 1;256:117996. doi: 10.1016/j.lfs.2020.117996. Epub 2020 Jun 23.
7
Alzheimer's Disease and Vascular Aging: JACC Focus Seminar.阿尔茨海默病与血管老化:美国心脏病学会焦点研讨会
J Am Coll Cardiol. 2020 Mar 3;75(8):942-951. doi: 10.1016/j.jacc.2019.10.062.
8
The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease.症状前阿尔茨海默病中疾病进展时间与认知连续测量指标的相对效率
Alzheimers Dement (N Y). 2019 Jul 18;5:308-318. doi: 10.1016/j.trci.2019.04.004. eCollection 2019.
9
Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease.多模态潜在因子分析阿尔茨海默病的脑萎缩、认知和 tau 异质性。
Neuroimage. 2019 Nov 1;201:116043. doi: 10.1016/j.neuroimage.2019.116043. Epub 2019 Jul 22.
10
Predicting the course of Alzheimer's progression.预测阿尔茨海默病的进展过程。
Brain Inform. 2019 Jun 28;6(1):6. doi: 10.1186/s40708-019-0099-0.